Chamuleau M, Nijland M, Lamers N, et al. First report on a successful screening program for MYC rearrangements and a prospective clinical trial based on MYC rearrangements in newly diagnosed DLBCL patients in the Netherlands. EHA 2018, abstract PS1025.
Isatuximab, carfilzomib en dexamethason bij gerecidiveerd multipel myeloom (IKEMA)
aug 2021 | MM